{"id":126534,"date":"2026-09-06T08:23:48","date_gmt":"2026-09-06T08:23:48","guid":{"rendered":"https:\/\/www.europesays.com\/ch\/126534\/"},"modified":"2026-09-06T08:23:48","modified_gmt":"2026-09-06T08:23:48","slug":"roche-licenses-rights-to-simcere-zaimings-sim-0660","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ch\/126534\/","title":{"rendered":"Roche licenses rights to Simcere Zaiming\u2019s SIM-0660"},"content":{"rendered":"<p>Immune<\/p>\n<p>Simcere Zaiming Pharmaceutical Co. Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., has entered into an exclusive global licensing agreement with F. Hoffmann-La Roche Ltd. for the development and commercialization of SIM-0660, a trispecific antibody with therapeutic potential across B-cell-mediated diseases.<\/p>\n<p><a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/520-bioworld-science\" rel=\"nofollow noopener\" target=\"_blank\">BioWorld Science<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/214-deals-and-m-a\" rel=\"nofollow noopener\" target=\"_blank\">Deals and M&amp;A<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/225-license\" rel=\"nofollow noopener\" target=\"_blank\">License<\/a> <a class=\"topic\" href=\"https:\/\/www.bioworld.com\/topics\/250-immune\" rel=\"nofollow noopener\" target=\"_blank\">Immune<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Immune Simcere Zaiming Pharmaceutical Co. Ltd., a subsidiary of Simcere Pharmaceutical Group Ltd., has entered into an exclusive&hellip;\n","protected":false},"author":2,"featured_media":126535,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[124],"tags":[17761,61785,49362,8568,929,15284,58397,134,61786,61780,60758],"class_list":["post-126534","post","type-post","status-publish","format-standard","has-post-thumbnail","category-roche","tag-autoimmune-disease","tag-b-cell-mediated-autoimmune-diseases","tag-bioworld-science","tag-deals-and-ma","tag-f-hoffmann-la-roche-ltd","tag-immune","tag-license","tag-roche","tag-sim-0660","tag-simcere-zaiming-pharmaceutical-co-ltd","tag-trispecific-antibodies"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ch\/117223139781417620","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/126534","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/comments?post=126534"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/posts\/126534\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media\/126535"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/media?parent=126534"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/categories?post=126534"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ch\/wp-json\/wp\/v2\/tags?post=126534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}